Earnings Feed
Start Free
Home/Insiders/Coyne Terrance P.
CT
SEC Insider//CIK 0001814876

Coyne Terrance P.

CIK 00018148761 companyNEW YORK, NY
SEC Profile

Transactions

50

Companies

1

Filings

8

CIK

0001814876

Recent Transactions

50 trades
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-03-02$47.01/sh−583→ 45,761 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-03-02$46.67/sh−22,487→ 109,177 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-03-02$47.01/sh−10,429→ 98,748 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-03-02$46.67/sh−1,292→ 46,344 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-02-23$45.32/sh−1,875→ 47,636 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-02-23$45.32/sh−32,916→ 131,664 total
  • Award
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-02-11+26,626→ 49,511 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-02-04$43.29/sh−19,076→ 164,580 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-02-04$43.29/sh−1,087→ 22,885 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-02-03$42.84/sh−6,195→ 23,972 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-02-03$42.84/sh−108,759→ 183,656 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-02-02$42.08/sh−102,581→ 292,415 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-02-02$42.08/sh−5,843→ 30,167 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-01-20$39.35/sh−65,832→ 394,996 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-01-20$39.35/sh−3,750→ 36,010 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-01-02$38.42/sh−65,832→ 460,828 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2026-01-02$38.42/sh−3,750→ 39,760 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-12-15$38.36/sh−3,750→ 43,510 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-12-15$38.36/sh−65,832→ 526,660 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-12-01$39.87/sh−65,832→ 592,492 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-12-01$39.87/sh−3,750→ 47,260 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-11-24$37.96/sh−624→ 51,010 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-11-24$38.67/sh−3,126→ 51,634 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-11-24$37.96/sh−10,686→ 658,324 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-11-24$38.67/sh−55,146→ 669,010 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-11-17$39.30/sh−3,750→ 54,760 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-11-17$39.30/sh−65,844→ 724,156 total
  • Award
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-11-05+6,168→ 58,510 total
  • Gift
    Royalty Pharma plc$RPRX

    LP interests in RPI US Partners 2019, LP

    2025-08-08−1,000→ 43,350 total
  • Award
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-08-06+3,696→ 52,342 total
  • Award
    Royalty Pharma plc$RPRX

    Class E Ordinary Shares

    2025-05-16+1,807,277→ 1,807,277 total
  • Award
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2025-05-08+48,646→ 48,646 total
  • Gift
    Royalty Pharma plc$RPRX

    ICAI Interests

    2024-08-12−2,000→ 44,350 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2023-08-10$30.75/sh−37,500→ 790,000 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2023-08-09$30.72/sh−37,500→ 827,500 total
  • Gift
    Royalty Pharma plc$RPRX

    ICAI Interests

    2023-08-08−1,650→ 46,350 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2023-07-13$30.93/sh−37,500→ 865,000 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2023-07-12$31.07/sh−37,500→ 902,500 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2022-11-08$43.47/sh−24,500→ 940,000 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2022-11-02$43.06/sh−5,500→ 964,500 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2022-08-01$43.19/sh−30,000→ 970,000 total
  • Conversion
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2021-05-07+1,000,000→ 1,000,000 total
  • Conversion
    Royalty Pharma plc$RPRX

    LP interests in RPI US Partners 2019, LP

    2021-05-07−100,000→ 22,945 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2021-03-03$46.83/sh−1,456→ 200,000 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2021-03-03$45.86/sh−11,001→ 201,456 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2021-03-03$45.09/sh−57,723→ 212,457 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2021-03-03$43.71/sh−29,820→ 270,180 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2021-03-02$47.88/sh−5,022→ 300,000 total
  • Sale
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2021-03-02$46.89/sh−94,978→ 305,022 total
  • Conversion
    Royalty Pharma plc$RPRX

    Class A Ordinary Shares

    2020-12-31+99,770→ 99,770 total

Companies

1

Recent Filings

8

Address

C/O ROYALTY PHARMA PLC 110 EAST 59TH STREET

NEW YORK, NY, 10022

View on SEC.gov